Healthcare contract research outsourcing is conducted by the pharmaceutical and medical device sectors for the development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development, and in the current scenario, clinical trials are conducted across multiple locations in various geographies. Increasing cost and time required for drug development are expected to propel the global healthcare contract research outsourcing market growth over the forecast period. Furthermore, the increasing number of patent expirations of leading drugs is also expected to aid in the growth of the market.
Market Dynamics
Increasing incidences of collaborations and partnerships are attributed to the growth of the global healthcare contract research outsourcing market. For instance, in September 2022, North American Science Associates, LLC (NAMSA), a Medical Devices Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc., a developer of the CGuard Embolic Prevention System (EPS) for the treatment of carotid artery disease and prevention of strokes, entered an outsourcing partnership to accelerate medical device development and commercialization.
Key features of the study:
- This report provides an in-depth analysis of the global healthcare contract research outsourcing market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global healthcare contract research outsourcing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- The key companies covered as a part of this study include, IQVIA Inc., Covance Inc (a subsidiary of Labcorp), Pharmaceutical Product Development Inc (a subsidiary of Thermo Fisher Scientific Inc), Parexel International (MA) Corporation, Charles River Laboratories, ICON plc, Medidata, Inventiv Health, Inc. (A subsidiary of Syneos Health), Medpace, and Piramal Enterprises Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global healthcare contract research outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare contract research outsourcing market
Detailed Segmentation:
- Global Healthcare Contract Research Outsourcing Market, By Services Type:
- Clinical Trials
- Regulatory Services
- Medical Writing
- Clinical Data Management
- Others
- Global Healthcare Contract Research Outsourcing Market, By End User:
- CROs
- Clinical Trial Laboratories
- AMCs
- Global Healthcare Contract Research Outsourcing Market, By Region:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
-
- IQVIA Inc
- Covance Inc (A subsidiary of Labcorp)
- Pharmaceutical Product Development Inc (A subsidiary of Thermo Fisher Scientific Inc)
- Parexel International (MA) Corporation.
- Charles River Laboratories
- ICON plc
- Medidata
- Inventiv Health, Inc. (A subsidiary of Syneos Health)
- Medpace
- Piramal Enterprises Ltd
